OR WAIT null SECS
August 28, 2018
The company is certified as a manufacturer of pressure vessels and components for use in China.
August 17, 2018
The acquisition is expected to support Emergent BioSolutions’ focus on public health threats and emerging infectious disease.
August 14, 2018
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
August 01, 2018
Determining how much containment is needed for API handling requires evaluation of multiple factors.
API can be mixed with silicone and other polymers to create drug-delivery combination products.
CMOs have been active over the past year in expanding their biologics production and capabilities.
This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.
Heightened uncertainty means CDMO executives need to play out planning scenarios.
A year’s worth of FDA warning letters suggest that API and finished drug manufacturers should strengthen their approach to continued process verification.
Real-life examples illustrate how to reduce the risks for each transferring partner and ensure that the development process meets regulatory requirements.